Your search returned 8 results.

Results
	1.	Nanoparticulate delivery can improve peroral bioavailability of cyclosporine and match Neoral Cmax sparing the kidney from damage. [electronic resource] by Ankola, D D Wadsworth, R M Ravi Kumar, M N V Producer: 20110802 In: Journal of biomedical nanotechnology vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Nanoparticles made of multi-block copolymer of lactic acid and ethylene glycol containing periodic side-chain carboxyl groups for oral delivery of cyclosporine A. [electronic resource] by Ankola, D D Battisti, A Solaro, R Kumar, M N V Ravi Producer: 20110106 In: Journal of the Royal Society, Interface vol. 7 Suppl 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy? [electronic resource] by Ankola, D D Viswanad, B Bhardwaj, V Ramarao, P Kumar, M N V Ravi Producer: 20071212 In: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. [electronic resource] by Shaikh, J Ankola, D D Beniwal, V Singh, D Kumar, M N V Ravi Producer: 20090824 In: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. [electronic resource] by Ratnam, D Venkat Ankola, D D Bhardwaj, V Sahana, D K Kumar, M N V Ravi Producer: 20070808 In: Journal of controlled release : official journal of the Controlled Release Society vol. 113 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat. [electronic resource] by Bhardwaj, V Ankola, D D Gupta, S C Schneider, M Lehr, C-M Kumar, M N V Ravi Producer: 20100428 In: Pharmaceutical research vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Preparation, characterization and in silico modeling of biodegradable nanoparticles containing cyclosporine A and coenzyme Q10. [electronic resource] by Ankola, D D Durbin, E W Buxton, G A Schäfer, J Bakowsky, U Kumar, M N V Ravi Producer: 20100316 In: Nanotechnology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia. [electronic resource] by Meena, A K Ratnam, D Venkat Chandraiah, G Ankola, D D Rao, P Rama Kumar, M N V Ravi Producer: 20080804 In: Lipids vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)